{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:40:53Z","timestamp":1762026053701,"version":"build-2065373602"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>After a\u00a0brief history of the emergence of modern therapy for acute ST-elevation myocardial infarction, we discuss the issues that dominate ongoing studies and are the focus of intense debates. The role of angiography, pharmacotherapy, thrombus aspiration, management of multi-vessel disease, mechanical complications and cardiogenic shock and the quest for myocardial salvage are discussed.<\/jats:p>","DOI":"10.1007\/s12471-020-01443-9","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T14:04:55Z","timestamp":1597154695000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ST-segment elevation myocardial infarction: Historical perspective and new horizons"],"prefix":"10.1007","volume":"28","author":[{"given":"F.","family":"Zijlstra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"1443_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/hrt.53.4.363","volume":"53","author":"MJ Davies","year":"1985","unstructured":"Davies\u00a0MJ, Thomas\u00a0AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart\u00a0J. 1985;53:363\u201373.","journal-title":"Br Heart J"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM198010163031601","volume":"303","author":"MA DeWood","year":"1980","unstructured":"DeWood\u00a0MA, Spores\u00a0J, Notske\u00a0R, et\u00a0al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N\u00a0Engl J Med. 1980;303:897\u2013902.","journal-title":"N Engl J Med"},{"key":"1443_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/clc.4960020507","volume":"2","author":"KP Rentrop","year":"1979","unstructured":"Rentrop\u00a0KP, Blanke\u00a0H, Wiegand\u00a0V, et\u00a0al. Acute myocardial infarction: intracoronary application of nitroglycerine and streptokinase. Clin Cardiol. 1979;2:354\u201363.","journal-title":"Clin Cardiol"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","volume":"1","author":"A Gruntzig","year":"1978","unstructured":"Gruntzig\u00a0A. Transluminal dilatation of coronary artery stenosis. Lancet. 1978;1:263.","journal-title":"Lancet"},{"key":"1443_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0002-8703(83)90639-7","volume":"106","author":"GO Hartzler","year":"1983","unstructured":"Hartzler\u00a0GO, Rutherford\u00a0BD, McConahay\u00a0DR, et\u00a0al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart\u00a0J. 1983;106:965\u201373.","journal-title":"Am Heart J"},{"key":"1443_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0140-6736(85)90584-7","volume":"2","author":"ML Simoons","year":"1985","unstructured":"Simoons\u00a0ML, Serruys\u00a0PW, van der Brand\u00a0M, et\u00a0al. Improved survival after early thrombolysis in acute myocardial infarction. A randomized trial by the Interuniversity Cardiology Institute in the Netherlands. Lancet. 1985;2:578\u201382.","journal-title":"Lancet"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1056\/NEJM199303113281002","volume":"328","author":"F Zijlstra","year":"1993","unstructured":"Zijlstra\u00a0F, de Boer\u00a0MJ, Hoorntje\u00a0JC, Reiffers\u00a0S, Reiber\u00a0JH, Suryapranata\u00a0H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N\u00a0Engl J Med. 1993;328:680\u20134.","journal-title":"N Engl J Med"},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM199303113281001","volume":"328","author":"CL Grines","year":"1993","unstructured":"Grines\u00a0CL, Browne\u00a0KF, Marco\u00a0J, et\u00a0al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N\u00a0Engl J Med. 1993;328:673\u20139.","journal-title":"N Engl J Med"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa025142","volume":"349","author":"HR Andersen","year":"2003","unstructured":"DANAMI\u20112 investigators, Andersen\u00a0HR, Nielsen\u00a0TT, Rasmussen\u00a0K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N\u00a0Engl J Med. 2003;349:733\u201342.","journal-title":"N Engl J Med"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","volume":"109","author":"G de Luca","year":"2004","unstructured":"de Luca\u00a0G, Suryapranata\u00a0H, Ottervanger\u00a0JP, Antman\u00a0EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223\u20135.","journal-title":"Circulation"},{"key":"1443_CR11","first-page":"151","volume":"12","author":"NM Ernst","year":"2004","unstructured":"Ernst\u00a0NM, de Boer\u00a0MJ, van \u2019t Hof\u00a0AW, et al. Prehospital triage for angiography-guided therapy for acute myocardial infarction. Neth Heart\u00a0J. 2004;12:151\u20136.","journal-title":"Neth Heart J"},{"key":"1443_CR12","first-page":"e1","volume":"1255","author":"AW Van \u2019t Hof","year":"2006","unstructured":"On-Time study group, Van \u2019t Hof\u00a0AW, Rasoel\u00a0S, van de Wetering\u00a0H, et al. Feasibility and benefit of pre-hospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction. Am Heart\u00a0J. 2006;1255:e1\u2013e5.","journal-title":"Am Heart J"},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","volume":"341","author":"CL Grines","year":"1999","unstructured":"Grines\u00a0CL, Cox\u00a0DA, Stone\u00a0GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent-PAMI study group. N\u00a0Engl J Med. 1999;341:1949\u201356.","journal-title":"N Engl J Med"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/heart.85.6.667","volume":"85","author":"H Suryapranata","year":"2001","unstructured":"Suryapranata\u00a0H, Ottervanger\u00a0JP, Nibbering\u00a0E, et al. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart. 2001;85:667\u201371.","journal-title":"Heart"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.jacc.2019.09.038","volume":"74","author":"P Chichareon","year":"2019","unstructured":"Chichareon\u00a0P, Modolo\u00a0R, Collet\u00a0C, et al. Efficacy and safety of stents in ST-segment elevation myocardial infarction. J\u00a0Am Coll Cardiol. 2019;74:2572\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"1443_CR16","first-page":"147","volume":"14","author":"YL Gu","year":"2006","unstructured":"Gu\u00a0YL, van den Heuvel\u00a0AF, Erasmus\u00a0ME, Zijlstra\u00a0F. Aortic dissection presenting as acute myocardial infarction: potential harm of antithrombin and antiplatelet therapy. Neth Heart\u00a0J. 2006;14:147\u20139.","journal-title":"Neth Heart J"},{"key":"1443_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez\u00a0B, James\u00a0S, Agewall\u00a0S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology. Eur Heart\u00a0J. 2018;39:119\u201377.","journal-title":"Eur Heart J"},{"key":"1443_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/eurheartj\/ehv053","volume":"36","author":"M Valgimigli","year":"2015","unstructured":"Valgimigli\u00a0M, Ariotti\u00a0S, Costa\u00a0F. Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a\u00a0consensus? Eur Heart\u00a0J. 2015;36:1219\u201322.","journal-title":"Eur Heart J"},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","volume":"381","author":"S Schupke","year":"2019","unstructured":"Schupke\u00a0S, Neumann\u00a0FJ, Menichelli\u00a0M, et al. ISAR-REACT 5 Trial Investigators .\u00a0Ticagrelor or prasugrel in patients with acute coronary syndromes. N\u00a0Engl J Med. 2019;381:1524\u201334.","journal-title":"N Engl J Med"},{"key":"1443_CR20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.118.038317","volume":"139","author":"F Franchi","year":"2019","unstructured":"Franchi\u00a0F, Rollini\u00a0F, Rivas\u00a0A, et al. Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous intervention: results of the CANTIC study. Circulation. 2019;139:1661\u201370.","journal-title":"Circulation"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","volume":"381","author":"DMF Claassens","year":"2019","unstructured":"Claassens\u00a0DMF, Vos\u00a0GJA, Bergmeijer\u00a0TO, et al. A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI. N\u00a0Engl J Med. 2019;381:1621\u201331.","journal-title":"N Engl J Med"},{"key":"1443_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.CIR.101.5.570","volume":"101","author":"EJ Topol","year":"2000","unstructured":"Topol\u00a0EJ, Yadav\u00a0JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570\u201380.","journal-title":"Circulation"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1053\/euhj.2001.3035","volume":"23","author":"JP Henriques","year":"2002","unstructured":"Henriques\u00a0JP, Zijlstra\u00a0F, Ottervanger\u00a0JP, et\u00a0al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart\u00a0J. 2002;23:1112\u20137.","journal-title":"Eur Heart J"},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa0706416","volume":"358","author":"T Svilaas","year":"2008","unstructured":"Svilaas\u00a0T, Vlaar\u00a0PJ, van der Horst\u00a0IC, et\u00a0al. Thrombus aspiration during primary percutaneous coronary intervention. N\u00a0Engl J Med. 2008;358:557\u201367.","journal-title":"N Engl J Med"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1405707","volume":"371","author":"B Lagerqvist","year":"2014","unstructured":"Lagerqvist\u00a0B, Frobert\u00a0O, Olivecrona\u00a0GK, et\u00a0al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N\u00a0Engl J Med. 2014;371:1111\u201320.","journal-title":"N Engl J Med"},{"key":"1443_CR26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","volume":"371","author":"SS Jolly","year":"2015","unstructured":"TOTAL investigators, Jolly\u00a0SS, Cairns\u00a0JA, Yusuf\u00a0S, et\u00a0al. Randomized trial of primary PCI with or without routine manual thrombectomy. N\u00a0Engl J Med. 2015;371:1389\u201398.","journal-title":"N Engl J Med"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","volume":"135","author":"SS Jolly","year":"2017","unstructured":"Jolly\u00a0SS, James\u00a0S, Dzavik\u00a0V, et al. Thrombus aspiration in ST-segment elevation myocardial infarction: an individual patient meta-analysis: Thrombectomy Trialists collaboration. Circulation. 2017;135:143\u201352.","journal-title":"Circulation"},{"key":"1443_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.4244\/EIJV6I6A129","volume":"6","author":"PJ Vlaar","year":"2011","unstructured":"Vlaar\u00a0PJ, de Smet\u00a0BJ, van den Heuvel\u00a0AF, et\u00a0al. Operator dependence of outcome after primary percutaneous coronary intervention. EuroIntervention. 2011;6:760\u20137.","journal-title":"EuroIntervention"},{"key":"1443_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","volume":"369","author":"DS Wald","year":"2013","unstructured":"Wald\u00a0DS, Morris\u00a0JK, Wald\u00a0NJ, et\u00a0al. Randomized trial of preventive angioplasty in myocardial infarction. N\u00a0Engl J Med. 2013;369:1115\u201323.","journal-title":"N Engl J Med"},{"key":"1443_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","volume":"65","author":"AH Gershlick","year":"2015","unstructured":"Gershlick\u00a0AH, Khan\u00a0JN, Kelly\u00a0DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the Culprit trial. J\u00a0Am Coll Cardiol. 2015;65:963\u201372.","journal-title":"J Am Coll Cardiol"},{"key":"1443_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","volume":"386","author":"T Engstrom","year":"2015","unstructured":"Engstrom\u00a0T, Kelbaek\u00a0H, Helqvist\u00a0S, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST-segment elevation and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomized controlled trial. Lancet. 2015;386:665\u201371.","journal-title":"Lancet"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","volume":"376","author":"PC Smits","year":"2017","unstructured":"Smits\u00a0PC, Abdel-Wahab\u00a0M, Neumann\u00a0FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N\u00a0Engl J Med. 2017;376:1234\u201344.","journal-title":"N Engl J Med"},{"key":"1443_CR33","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","volume":"381","author":"SR Mehta","year":"2019","unstructured":"Mehta\u00a0SR, Wood\u00a0DA, Storey\u00a0RF, et\u00a0al. Complete revascularization with multivessel PCI for myocardial infarction. N\u00a0Engl J Med. 2019;381:1411\u201321.","journal-title":"N Engl J Med"},{"key":"1443_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1056\/NEJMe1910898","volume":"381","author":"L Kober","year":"2019","unstructured":"Kober\u00a0L, Engstrom\u00a0T. A more complete picture of revascularization in STEMI. N\u00a0Engl J Med. 2019;381:1472\u20134.","journal-title":"N Engl J Med"},{"key":"1443_CR35","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","volume":"379","author":"H Thiele","year":"2018","unstructured":"Thiele\u00a0H, Akin\u00a0I, Sandri\u00a0M, et al. One-year outcomes after PCI strategies in cardiogenic shock. N\u00a0Engl J Med. 2018;379:1699\u2013710.","journal-title":"N Engl J Med"},{"key":"1443_CR36","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","volume":"380","author":"E Nagel","year":"2019","unstructured":"Nagel\u00a0E, Greenwood\u00a0JP, McCann\u00a0GP, et\u00a0al. Magnetic resonance perfusion or fractional flow reserve in coronary disease. N\u00a0Engl J Med. 2019;380:2418\u201328.","journal-title":"N Engl J Med"},{"key":"1443_CR37","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.jcin.2019.04.039","volume":"12","author":"A Elbadawy","year":"2019","unstructured":"Elbadawy\u00a0A, Elgendy\u00a0IY, Mahmoud\u00a0K, et\u00a0al. Temporal trends and outcomes of mechanical complications in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2019;12:1825\u201336.","journal-title":"JACC Cardiovasc Interv"},{"key":"1443_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele\u00a0H, Zeymer\u00a0U, Neumann\u00a0FJ, et\u00a0al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N\u00a0Engl J Med. 2012;367:1287\u201396.","journal-title":"N Engl J Med"},{"key":"1443_CR39","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMe1209601","volume":"367","author":"CM O\u2019Connor","year":"2012","unstructured":"O\u2019Connor\u00a0CM, Rogers\u00a0JG. Evidence for overturning the guidelines in cardiogenic shock. N\u00a0Engl J Med. 2012;367:1349\u201350.","journal-title":"N Engl J Med"},{"key":"1443_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12471-013-0509-5","volume":"22","author":"JJ Brugts","year":"2014","unstructured":"Brugts\u00a0JJ, Manintveld\u00a0O, Constantinescu\u00a0A, et al. Preventing LVAD implantation by early short-term mechanical support and prolonged inodilator therapy: A case series with acute refractory cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation and optimized medical strategy. Neth Heart\u00a0J. 2014;22:176\u201381.","journal-title":"Neth Heart J"},{"key":"1443_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10557-019-06901-0","volume":"33","author":"J Allencherril","year":"2019","unstructured":"Allencherril\u00a0J, Jneid\u00a0H, Atar\u00a0D, et al. Pathophysiology, diagnosis, and management of the no-reflow phenomenon. Cardiovasc Drugs Ther. 2019;33:589\u201397.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1443_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/cvr\/cvz301","volume":"116","author":"LSF Konijnenberg","year":"2020","unstructured":"Konijnenberg\u00a0LSF, Damman\u00a0P, Duncker\u00a0DJ, et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res. 2020;116:787\u2013805.","journal-title":"Cardiovasc Res"},{"key":"1443_CR43","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa1816897","volume":"380","author":"JS Lemkes","year":"2019","unstructured":"Lemkes\u00a0JS, Janssens\u00a0GN, van der Hoeven\u00a0NW, et al. Coronary angiography after cardiac arrest without ST-segment elevation. N\u00a0Engl J Med. 2019;380:1397\u2013407.","journal-title":"N Engl J Med"},{"key":"1443_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.105.606145","volume":"114","author":"LR Dekker","year":"2006","unstructured":"Dekker\u00a0LR, Bezzina\u00a0CR, Henriques\u00a0JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a\u00a0case-control study in acute myocardial infarction patients. Circulation. 2006;114:1140\u20135.","journal-title":"Circulation"},{"key":"1443_CR45","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1161\/CIRCULATIONAHA.114.010905","volume":"130","author":"MT Blom","year":"2014","unstructured":"Blom\u00a0MT, Beesems\u00a0SG, Homma\u00a0PC, et al. Improved survival after out-of-hospital cardiac arrest and use of automated external defibrillators. Circulation. 2014;130:1868\u201375.","journal-title":"Circulation"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-020-01443-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:41:31Z","timestamp":1650537691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-020-01443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":45,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01443-9","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"type":"print","value":"1568-5888"},{"type":"electronic","value":"1876-6250"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"11 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.\u00a0Zijlstra, H.\u00a0Suryapranata and M.\u2011J.\u00a0de Boer declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}